HHS announces 2024 actions to protect contraceptive care

上市批准
HHS announces 2024 actions to protect contraceptive care
Preview
来源: Pharmaceutical Technology
The US Department of Health and Human Services declared its next steps in protecting contraceptive coverage. Credit: Mark Van Scyoc via Shutterstock
Following the 51st anniversary of Roe v. Wade on 22 January, the US Department for Health and Human Services (HHS) announced its plans to increase access and protections for contraceptive care.
In a new frequently asked questions document, the Departments of Labor, HHS, and the Treasury, highlighted a commitment to the 2021 Health Resources and Services Administration (HRSA) -supported Women’s Preventive Services Guidelines (HRSA-supported Guidelines). These recommendations prioritsed giving adolescent and adult women access to the full range of contraceptives and contraceptive care to mitigate the risk of unexpected pregnancies and produce better birth outcomes. The guidelines also pushed for full availability of US Food and Drug Administration (FDA) approved contraceptives.
HHS also updated the Medicare Part D formulary clinical review process for 2024 to add more birth control types such as intramuscular long-acting contraceptives and intrauterine devices (IUDs).
The recent announcement is in line President Joe Biden’s June 2023 executive order on “strengthening access to affordable, high-quality contraception and family planning services” that illustrated the administration’s plans to improve access to contraception “without out-of-pocket expenses, under the Affordable Care Act (ACA)”.
It also highlighted the importance of maintaining access to emergency and over-the-counter contraceptive. Following this, the FDA approved Perrigo’s Opill (norgestrel) as the first over-the-counter contraceptive available in the US.
The departments’ new guidance arrived in response to new barriers to contraceptive coverage that have arisen since the June 2022 overturning of Roe v. Wade.
The Office of Population Affairs estimates that 37.9 million women require contraceptive services in the US. As of October 2023, thirteen states, including California, Colorado and Florida, had protections for contraceptive rights. The Guttmacher Institute also reported that as of September 2023, 20 states and DC have allowed certain employers to choose not to follow the contraceptive coverage mandate.
In a 22 January press release, the HHS secretary Xavier Bercerra said, “Through the ACA’s Medicaid expansion, Medicaid has also dramatically improved access to contraception and family planning and measurably improved pregnancy, birth, and postpartum health outcomes. But we know there is more work ahead to ensure that all Medicaid enrollees who want or need access to affordable contraception can obtain it.”
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。